Experience

Emergent BioSolutions

• United States
• Biotechnology Research
• 700 & Above Employee

• Vice President of Product Development

  • May 2023 - Present

• Vice President, Devices R&D and CNS Therapeutic Area Lead

  • May 2022 - May 2023

• Interim Head of CNS Therapeutic Area and Devices R&D

  • Oct 2021 - May 2022

  -Following consolidation of the Vaccines, Therapeutics and Device Business Units into one unified R&D organization, I led the legacy devices function under the renamed CNS Therapeutic Area and Devices.-Accountable for the delivery of the pipeline programs within this therapeutic area of the business.-Oversight of CMC drug development, device engineering, combination product development and CNS Project management functions totalling > 20 employees working hybrid, remote and on site.

• Sr. Director, Drug Development

  • Jan 2020 - May 2022

  -Responsible for all CMC Drug and Drug/Device Combination Product development within the Device Business Unit.-Responsible for the Drug Development teams across two sites - Dublin, IRE and Gaithersburg, MD.

• Director, Drug Development

  • May 2019 - Jan 2020

  -Responsible for CMC Drug and Drug/Device Combination product development programs led by the Dublin R&D team.-This included Narcan LCM and MCM Pipeline Products both internally and externally funded.



Teva Pharmaceuticals

• Israel
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Associate Director, Gx R&D

  • Mar 2015 - May 2019



Actavis

• Lead Development Chemist

  • Jun 2014 - Mar 2015



Warner Chilcott UK Ltd

• Larne

• Development Chemist

  • Dec 2011 - Jun 2014



Warner Chilcott

• Senior Development Scientist

  • Jan 2011 - Dec 2011

• Development Scientist

  • May 2009 - Jan 2011



XenoSense Ltd

• Belfast, United Kingdom

• Research Scientist

  • Feb 2006 - May 2009